MarketCap
Facebook
X
TelegramQuarterly report 2023-Q2
added 08-02-2023
NuVasive ROCE Ratio 2011-2026 | NUVA
Annual ROCE Ratio NuVasive
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 7.21 | 6.7 | 8.26 | 7.4 | 8.72 | 5.21 | 3.11 | 4.67 | 3.75 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.72 | 3.11 | 6.12 |
ROCE Ratio of other stocks in the Medical devices industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
15.77 | $ 190.07 | 2.73 % | $ 14.2 B |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-6.16 | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
1334.24 | - | -26.83 % | $ 2.62 M | USA |
 |
Avinger
AVGR
|
268.22 | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-11.39 | - | - | $ 3.31 B | USA |
 |
AdaptHealth Corp.
AHCO
|
5.98 | $ 12.66 | 0.64 % | $ 1.71 B | USA |
 |
Allied Healthcare Products
AHPI
|
-24.19 | - | 3.58 % | $ 2.21 M | USA |
 |
Aziyo Biologics
AZYO
|
-97.25 | - | 1.37 % | $ 20.5 M | USA |
 |
Lianluo Smart Limited
LLIT
|
-89.32 | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
-191.02 | - | -5.86 % | $ 30.6 M | USA |
 |
BioSig Technologies
BSGM
|
-53.38 | - | 37.08 % | $ 85.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-50.21 | $ 3.49 | -2.79 % | $ 131 M |  France |
 |
Conformis
CFMS
|
-85.42 | - | - | $ 16.4 M | USA |
 |
Boston Scientific Corporation
BSX
|
14.91 | $ 64.23 | 1.28 % | $ 95.1 B | USA |
 |
Electromed
ELMD
|
22.36 | $ 26.06 | 2.64 % | $ 220 M | USA |
 |
Apollo Endosurgery
APEN
|
-96.4 | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
-14.35 | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-249.86 | $ 0.66 | 8.2 % | $ 41.1 M | USA |
 |
ClearPoint Neuro
CLPT
|
-86.24 | $ 11.79 | 12.29 % | $ 334 M | USA |
 |
Dynatronics Corporation
DYNT
|
-75.2 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-110.81 | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
0.33 | - | -4.14 % | $ 702 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-8.49 | $ 16.75 | 1.33 % | $ 393 M | USA |
 |
Second Sight Medical Products
EYES
|
-175.18 | - | -0.97 % | $ 54.4 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-804.35 | - | 1.15 % | $ 34.5 M | USA |
 |
Soliton, Inc.
SOLY
|
-46.49 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-124.26 | - | -1.98 % | $ 98.3 M | USA |
 |
LENSAR
LNSR
|
94.46 | $ 5.93 | 2.24 % | $ 70.9 M | USA |
 |
GBS
GBS
|
-355.28 | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-22.41 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-10.4 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-344.26 | - | - | $ 111 M |  Canada |
 |
Globus Medical
GMED
|
10.49 | $ 95.25 | 2.7 % | $ 12.9 B | USA |
 |
Helius Medical Technologies
HSDT
|
-528.85 | $ 2.12 | 2.91 % | $ 1.29 M | USA |
 |
Butterfly Network
BFLY
|
-44.07 | $ 5.45 | 3.02 % | $ 1.15 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-36.94 | - | - | $ 955 M | USA |
 |
Inogen
INGN
|
-15.71 | $ 6.82 | 3.49 % | $ 181 M | USA |
 |
IRIDEX Corporation
IRIX
|
-52.23 | $ 1.06 | 1.92 % | $ 18 M | USA |
 |
BIOLASE
BIOL
|
7261.94 | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
0.59 | $ 10.86 | 0.28 % | $ 389 M | USA |
 |
Inspire Medical Systems
INSP
|
6.52 | $ 57.59 | 2.02 % | $ 1.69 B | USA |
 |
CONMED Corporation
CNMD
|
9.93 | $ 39.08 | 3.09 % | $ 1.21 B | USA |
 |
LivaNova PLC
LIVN
|
16.62 | $ 67.12 | 3.25 % | $ 3.66 B |  Britain |
 |
Integer Holdings Corporation
ITGR
|
12.67 | $ 90.2 | 2.07 % | $ 3.13 B | USA |
 |
FONAR Corporation
FONR
|
2.84 | $ 18.8 | 0.21 % | $ 123 M | USA |
 |
Invacare Corporation
IVC
|
-99.23 | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
12.23 | $ 80.99 | 2.45 % | $ 47.4 B | USA |
 |
Sintx Technologies
SINT
|
-366.03 | $ 2.7 | 0.75 % | $ 7.49 M | USA |
 |
Penumbra
PEN
|
13.26 | $ 332.13 | 0.2 % | $ 12.9 B | USA |
 |
Cutera
CUTR
|
-60.43 | - | -10.19 % | $ 1.99 M | USA |